Technology Solutions

ERT opening Innovation Lab in Boston

Monday, February 8, 2016

ERT is launching an Innovation Lab in Boston on February 9. A cloud platform solutions provider, ERT supplies the industry, sponsors and CROs alike, with technology, services and consultancy. The company is known for first-in-the-industry features such as wireless eDiaries to collect electronic Clinical Outcome Assessments (eCOA).

[Read More]

Icon releases Flex Advantage for patient randomization

Tuesday, February 2, 2016

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has launched Flex Advantage, a next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities and supports the execution of adaptive trials.

[Read More]

Three Questions: Drew Schiller, Validic

Monday, January 25, 2016

CWWeekly presents this feature as a way to shine the spotlight on issues faced by executives in the clinical trials space. Writer Suz Redfearn spoke with Drew Schiller, chief technology officer and co-founder of Validic, an IT company that con­nects data from wearable and medical devices to companies across the healthcare ecosystem.

[Read More]

Veeva Systems launches new TMF Maturity Model

Monday, January 25, 2016

Veeva Systems has introduced the Veeva TMF Maturity Model, a complimentary consultative service designed to assess the state of a life sciences organization’s trial master file (TMF) strategy and provide a roadmap for improvement. The Veeva TMF Maturity Model gives practical, step-by-step guidance to help companies transform their TMF from a static archive into a strategic asset that can help increase the efficiency of clinical trials. It is available as a self-service online tool or as a more detailed, in-person evaluation with a seasoned subject matter expert.

[Read More]

UCL launches $55M technology investment fund

Wednesday, January 20, 2016

UCL is launching the UCL Technology Fund to invest £50 million ($55 million) in commercializing its research emerging over the next five years. The Fund will be used to support academics whose research has commercial potential, with funding for early stage proof-of-concept, licensing projects and new spinout companies.

[Read More]

Wearables track drug effectiveness in Parkinson’s patients

Monday, January 18, 2016

Cynapsus and the Michael J. Fox Foundation (MJFF) are partnering to incorporate a wearable device into a phase III study of patients with Parkinson’s disease. Similar to a smartwatch, the device is equipped with motion sensors to detect when patients have an “OFF” episode—a period where medicine stops working and motor impairment symptoms return. The symptoms include muscle stiffness or problems with starting movements, such as starting to walk or getting out of a chair.

[Read More]